Article

The Role of Decision Impact Studies in Genomic Medicine in Cancer Care: A Scoping Review and Bibliometric Analysis Protocol

2021-11-15

Abstract excerpt

<title>Abstract</title> <p>BackgroundDecision impact studies have become increasingly prevalent in oncology in recent years, particularly in breast cancer prognostic research. Such studies, which aim to evaluate the impact of a test on clinical decision-making, appear to be a new form of knowledge with the potential to impact clinical practice and regulatory decision-making in genomic medicine. Yet their origins,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2623a88d-5b1b-5597-8df6-0264cd461030
DOI: 10.21203/rs.3.rs-1062152/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Role of Decision Impact Studies in Genomic Medicine in Cancer Care: A Scoping Review and Bibliometric Analysis ProtocolDOI 10.21203/rs.3.rs-1062152/v1Read

Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping reviewSemantic proximity Read

Rate of change in investigational treatment options: An analysis of reports from a large precision oncology decision support effort.Semantic proximity Read

Genetic and other omics-based information in the most-cited recent clinical trialsSemantic proximity Read

High-impact trials with genetic and -omics information focus on cancer mutations, are industry-funded, and less transparent.Semantic proximity Read

Implementation of a Clinical Decision Support System for Precision Oncology across an Academic NetworkSemantic proximity Read

Development of an electronic decision aid tool to facilitate mainstream genetic testing in ovarian cancer patientsSemantic proximity Read

Technical desiderata for the integration of genomic data with clinical decision supportSemantic proximity Read

Cancer clinical trials in the era of genomic signatures: Biomedical innovation, clinical utility, and regulatory-scientific hybridsSemantic proximity Read

Statistical and practical considerations for clinical evaluation of predictive biomarkers.Semantic proximity Read

Global Inequities in Precision Oncology Drug Development: A Cross-Sectional Analysis of FDA Approvals Between 2017-2024Semantic proximity Read

Genomic expertise in action: molecular tumour boards and decision‐making in precision oncologySemantic proximity Read

Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies.Semantic proximity Read